Neurologic complications of systemic cancer.
Patients with cancer commonly suffer neurologic disabilities. These neurologic disorders can be either metastatic to the brain, spinal cord, leptomeninges, or peripheral nerves or nonmetastatic including infections, vascular problems, metabolic abnormalities, side effects of therapy, or paraneoplastic syndromes. Careful diagnostic evaluation of patients with cancer and neurologic symptoms often indicates effective therapy.
D001099:Arachnoid; D001424:Bacterial Infections / Q000209:etiology / Q000276:immunology; D001921:Brain / Q000098:blood supply; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000556:secondary / Q000628:therapy; D002561:Cerebrovascular Disorders / Q000209:etiology; D002945:Cisplatin / Q000009:adverse effects; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D004569:Electroencephalography; D004696:Endocarditis / Q000209:etiology; D005472:Fluorouracil / Q000009:adverse effects; D006801:Humans; D008175:Lung Neoplasms; D008545:Melanoma; D008577:Meningeal Neoplasms / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000503:physiopathology / Q000556:secondary / Q000628:therapy; D008727:Methotrexate / Q000009:adverse effects; D009369:Neoplasms / Q000150:complications*; D009422:Nervous System Diseases / Q000209:etiology*; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000209:etiology; D010841:Pia Mater; D011379:Prognosis; D013117:Spinal Cord Compression / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology; D013120:Spinal Cord Neoplasms / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000556:secondary / Q000628:therapy; D014057:Tomography, X-Ray Computed; D014748:Vinca Alkaloids / Q000009:adverse effects
D014748:Vinca Alkaloids; D002945:Cisplatin; D005472:Fluorouracil; D008727:Methotrexate